In January 2006, IVAX Argentina S.A. became a member of the Teva Group when the acquisition of IVAX Corporation by Teva Pharmaceutical Industries Ltd. (“Teva”) was finalized. Teva is a global pharmaceutical company specializing in the development, production and marketing of generic and proprietary branded pharmaceuticals as well as active pharmaceutical ingredients. Teva is among the top 20 pharmaceutical companies and among the largest generic pharmaceutical companies in the world. With its head office in Israel, Teva has over a century of history, operations in over 50 countries and approx. 25,000 employees worldwide. The acquisition of IVAX strengthened the position of Teva in Central and Eastern Europe, in Latin America and complementary operations in North America and Europe. Identified as IVAX Argentina since 2001, the presence of our Company in the country, through the many prestigious of its products, dating back to the decade of 1950. In the vast line of proprietary products that IVAX Argentina offers, we can find resources and cutting-edge therapeutic formulations of traditional roots and comprehensive utilization. Among the latter, can be mentioned in Dexalergin®, with more than 40 years, maintains full force with high levels of acceptance and consumption. For over 50 years of rich history was cementing and strengthening the close relationship that now exists between the Company and the professional community related to health care. The offering provided novel therapeutic options, the continued support for academic activities, the close link with societies and medical and pharmaceutical institutions, were gaining recognition for our Company and trust that today enjoys by those.